nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—CYP1A2—Carmustine—malignant glioma	0.151	0.569	CbGbCtD
Conjugated Estrogens—CYP3A4—Temozolomide—malignant glioma	0.114	0.43	CbGbCtD
Conjugated Estrogens—SLC22A8—choroid plexus—malignant glioma	0.0304	0.155	CbGeAlD
Conjugated Estrogens—COMT—telencephalic ventricle—malignant glioma	0.011	0.0561	CbGeAlD
Conjugated Estrogens—ABCC11—embryo—malignant glioma	0.00978	0.0499	CbGeAlD
Conjugated Estrogens—Clotting—Temozolomide—malignant glioma	0.00825	0.0352	CcSEcCtD
Conjugated Estrogens—Embolism—Temozolomide—malignant glioma	0.00459	0.0196	CcSEcCtD
Conjugated Estrogens—Cyst—Carmustine—malignant glioma	0.00456	0.0195	CcSEcCtD
Conjugated Estrogens—Thrombosis—Carmustine—malignant glioma	0.00431	0.0184	CcSEcCtD
Conjugated Estrogens—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00398	0.017	CcSEcCtD
Conjugated Estrogens—ESR1—blood vessel—malignant glioma	0.00391	0.0199	CbGeAlD
Conjugated Estrogens—SLCO1C1—telencephalon—malignant glioma	0.0039	0.0199	CbGeAlD
Conjugated Estrogens—Necrosis—Carmustine—malignant glioma	0.00388	0.0166	CcSEcCtD
Conjugated Estrogens—Abscess—Carmustine—malignant glioma	0.00385	0.0165	CcSEcCtD
Conjugated Estrogens—Coagulopathy—Temozolomide—malignant glioma	0.00378	0.0162	CcSEcCtD
Conjugated Estrogens—SLCO3A1—retina—malignant glioma	0.00373	0.019	CbGeAlD
Conjugated Estrogens—SLC51A—central nervous system—malignant glioma	0.00364	0.0185	CbGeAlD
Conjugated Estrogens—Extravasation—Carmustine—malignant glioma	0.00349	0.0149	CcSEcCtD
Conjugated Estrogens—Accidental injury—Carmustine—malignant glioma	0.00344	0.0147	CcSEcCtD
Conjugated Estrogens—SLCO4A1—retina—malignant glioma	0.0034	0.0173	CbGeAlD
Conjugated Estrogens—Breast pain—Temozolomide—malignant glioma	0.00338	0.0144	CcSEcCtD
Conjugated Estrogens—Amenorrhoea—Temozolomide—malignant glioma	0.00335	0.0143	CcSEcCtD
Conjugated Estrogens—SLCO4A1—telencephalon—malignant glioma	0.00312	0.0159	CbGeAlD
Conjugated Estrogens—ESR2—brainstem—malignant glioma	0.00312	0.0159	CbGeAlD
Conjugated Estrogens—Pulmonary embolism—Carmustine—malignant glioma	0.00305	0.013	CcSEcCtD
Conjugated Estrogens—Musculoskeletal pain—Temozolomide—malignant glioma	0.00298	0.0127	CcSEcCtD
Conjugated Estrogens—COMT—brainstem—malignant glioma	0.00298	0.0152	CbGeAlD
Conjugated Estrogens—Pulmonary embolism—Temozolomide—malignant glioma	0.00295	0.0126	CcSEcCtD
Conjugated Estrogens—Vaginal inflammation—Temozolomide—malignant glioma	0.00295	0.0126	CcSEcCtD
Conjugated Estrogens—SLC51A—brain—malignant glioma	0.00289	0.0147	CbGeAlD
Conjugated Estrogens—SLCO1C1—midbrain—malignant glioma	0.0028	0.0143	CbGeAlD
Conjugated Estrogens—Vaginal infection—Temozolomide—malignant glioma	0.00278	0.0119	CcSEcCtD
Conjugated Estrogens—ESR2—telencephalon—malignant glioma	0.00277	0.0141	CbGeAlD
Conjugated Estrogens—Neoplasm—Carmustine—malignant glioma	0.00276	0.0118	CcSEcCtD
Conjugated Estrogens—SLCO1C1—spinal cord—malignant glioma	0.00273	0.0139	CbGeAlD
Conjugated Estrogens—SLCO3A1—medulla oblongata—malignant glioma	0.00269	0.0137	CbGeAlD
Conjugated Estrogens—Neoplasm—Temozolomide—malignant glioma	0.00266	0.0114	CcSEcCtD
Conjugated Estrogens—Sepsis—Carmustine—malignant glioma	0.00265	0.0113	CcSEcCtD
Conjugated Estrogens—COMT—telencephalon—malignant glioma	0.00264	0.0135	CbGeAlD
Conjugated Estrogens—Phlebitis—Carmustine—malignant glioma	0.00257	0.011	CcSEcCtD
Conjugated Estrogens—Thrombophlebitis—Carmustine—malignant glioma	0.00256	0.0109	CcSEcCtD
Conjugated Estrogens—Swelling—Carmustine—malignant glioma	0.00251	0.0107	CcSEcCtD
Conjugated Estrogens—Thrombophlebitis—Temozolomide—malignant glioma	0.00247	0.0106	CcSEcCtD
Conjugated Estrogens—SLCO3A1—midbrain—malignant glioma	0.00246	0.0125	CbGeAlD
Conjugated Estrogens—SLCO4A1—medulla oblongata—malignant glioma	0.00245	0.0125	CbGeAlD
Conjugated Estrogens—SLCO2B1—telencephalon—malignant glioma	0.00243	0.0124	CbGeAlD
Conjugated Estrogens—Injury—Carmustine—malignant glioma	0.00241	0.0103	CcSEcCtD
Conjugated Estrogens—SLCO3A1—spinal cord—malignant glioma	0.0024	0.0122	CbGeAlD
Conjugated Estrogens—SLC10A1—central nervous system—malignant glioma	0.00236	0.012	CbGeAlD
Conjugated Estrogens—ESR1—embryo—malignant glioma	0.00233	0.0119	CbGeAlD
Conjugated Estrogens—SLCO4A1—midbrain—malignant glioma	0.00224	0.0114	CbGeAlD
Conjugated Estrogens—SLCO1A2—telencephalon—malignant glioma	0.00224	0.0114	CbGeAlD
Conjugated Estrogens—Purpura—Temozolomide—malignant glioma	0.00222	0.00948	CcSEcCtD
Conjugated Estrogens—SLCO1C1—central nervous system—malignant glioma	0.00222	0.0113	CbGeAlD
Conjugated Estrogens—SLCO4A1—spinal cord—malignant glioma	0.00219	0.0112	CbGeAlD
Conjugated Estrogens—ESR1—brainstem—malignant glioma	0.00214	0.0109	CbGeAlD
Conjugated Estrogens—COMT—medulla oblongata—malignant glioma	0.00207	0.0106	CbGeAlD
Conjugated Estrogens—Mood swings—Temozolomide—malignant glioma	0.00203	0.00865	CcSEcCtD
Conjugated Estrogens—Hypokalaemia—Carmustine—malignant glioma	0.00201	0.0086	CcSEcCtD
Conjugated Estrogens—Dehydration—Temozolomide—malignant glioma	0.00199	0.00849	CcSEcCtD
Conjugated Estrogens—SLCO3A1—central nervous system—malignant glioma	0.00195	0.00993	CbGeAlD
Conjugated Estrogens—Hypokalaemia—Temozolomide—malignant glioma	0.00195	0.00831	CcSEcCtD
Conjugated Estrogens—Breast disorder—Temozolomide—malignant glioma	0.00193	0.00825	CcSEcCtD
Conjugated Estrogens—Dysphagia—Carmustine—malignant glioma	0.00191	0.00817	CcSEcCtD
Conjugated Estrogens—SLCO2B1—medulla oblongata—malignant glioma	0.00191	0.00973	CbGeAlD
Conjugated Estrogens—SLCO3A1—cerebellum—malignant glioma	0.0019	0.00971	CbGeAlD
Conjugated Estrogens—ESR1—telencephalon—malignant glioma	0.0019	0.00967	CbGeAlD
Conjugated Estrogens—COMT—midbrain—malignant glioma	0.0019	0.00967	CbGeAlD
Conjugated Estrogens—SLC10A1—brain—malignant glioma	0.00187	0.00954	CbGeAlD
Conjugated Estrogens—Abdominal distension—Temozolomide—malignant glioma	0.00186	0.00795	CcSEcCtD
Conjugated Estrogens—COMT—spinal cord—malignant glioma	0.00185	0.00943	CbGeAlD
Conjugated Estrogens—Dysphagia—Temozolomide—malignant glioma	0.00185	0.00789	CcSEcCtD
Conjugated Estrogens—ABCC1—telencephalon—malignant glioma	0.00184	0.00936	CbGeAlD
Conjugated Estrogens—Sweating increased—Temozolomide—malignant glioma	0.0018	0.00769	CcSEcCtD
Conjugated Estrogens—Bronchitis—Temozolomide—malignant glioma	0.00178	0.00759	CcSEcCtD
Conjugated Estrogens—SLCO4A1—central nervous system—malignant glioma	0.00178	0.00905	CbGeAlD
Conjugated Estrogens—SLCO1C1—brain—malignant glioma	0.00176	0.00897	CbGeAlD
Conjugated Estrogens—SLCO1A2—medulla oblongata—malignant glioma	0.00176	0.00896	CbGeAlD
Conjugated Estrogens—SLCO4A1—cerebellum—malignant glioma	0.00174	0.00885	CbGeAlD
Conjugated Estrogens—Dysuria—Temozolomide—malignant glioma	0.00173	0.00738	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Carmustine—malignant glioma	0.00173	0.00737	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00172	0.00734	CcSEcCtD
Conjugated Estrogens—SLCO2B1—spinal cord—malignant glioma	0.0017	0.00868	CbGeAlD
Conjugated Estrogens—Depression—Carmustine—malignant glioma	0.0017	0.00726	CcSEcCtD
Conjugated Estrogens—Weight increased—Temozolomide—malignant glioma	0.00168	0.00718	CcSEcCtD
Conjugated Estrogens—Renal failure—Carmustine—malignant glioma	0.00168	0.00716	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Carmustine—malignant glioma	0.00167	0.00714	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Temozolomide—malignant glioma	0.00167	0.00712	CcSEcCtD
Conjugated Estrogens—Infestation—Temozolomide—malignant glioma	0.00165	0.00704	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Temozolomide—malignant glioma	0.00165	0.00704	CcSEcCtD
Conjugated Estrogens—Depression—Temozolomide—malignant glioma	0.00164	0.00702	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Temozolomide—malignant glioma	0.00162	0.0069	CcSEcCtD
Conjugated Estrogens—SLC22A6—brain—malignant glioma	0.00161	0.00821	CbGeAlD
Conjugated Estrogens—SLCO1A2—midbrain—malignant glioma	0.00161	0.00819	CbGeAlD
Conjugated Estrogens—ESR2—central nervous system—malignant glioma	0.00157	0.00803	CbGeAlD
Conjugated Estrogens—SLCO1A2—spinal cord—malignant glioma	0.00157	0.00799	CbGeAlD
Conjugated Estrogens—Hepatobiliary disease—Temozolomide—malignant glioma	0.00156	0.00666	CcSEcCtD
Conjugated Estrogens—SLCO3A1—brain—malignant glioma	0.00155	0.00789	CbGeAlD
Conjugated Estrogens—Sinusitis—Temozolomide—malignant glioma	0.00155	0.0066	CcSEcCtD
Conjugated Estrogens—ABCB1—blood vessel—malignant glioma	0.00154	0.00787	CbGeAlD
Conjugated Estrogens—ESR2—cerebellum—malignant glioma	0.00154	0.00784	CbGeAlD
Conjugated Estrogens—Hypoaesthesia—Carmustine—malignant glioma	0.00152	0.00651	CcSEcCtD
Conjugated Estrogens—ABCG2—telencephalon—malignant glioma	0.00152	0.00775	CbGeAlD
Conjugated Estrogens—Oedema peripheral—Carmustine—malignant glioma	0.00151	0.00644	CcSEcCtD
Conjugated Estrogens—COMT—central nervous system—malignant glioma	0.0015	0.00765	CbGeAlD
Conjugated Estrogens—ABCC3—central nervous system—malignant glioma	0.00148	0.00756	CbGeAlD
Conjugated Estrogens—Visual impairment—Carmustine—malignant glioma	0.00148	0.0063	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Temozolomide—malignant glioma	0.00147	0.00629	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Temozolomide—malignant glioma	0.00147	0.00627	CcSEcCtD
Conjugated Estrogens—COMT—cerebellum—malignant glioma	0.00147	0.00748	CbGeAlD
Conjugated Estrogens—Oedema peripheral—Temozolomide—malignant glioma	0.00146	0.00622	CcSEcCtD
Conjugated Estrogens—Eye disorder—Carmustine—malignant glioma	0.00143	0.00611	CcSEcCtD
Conjugated Estrogens—Visual impairment—Temozolomide—malignant glioma	0.00143	0.00609	CcSEcCtD
Conjugated Estrogens—SLCO4A1—brain—malignant glioma	0.00141	0.00718	CbGeAlD
Conjugated Estrogens—Erythema multiforme—Temozolomide—malignant glioma	0.0014	0.00597	CcSEcCtD
Conjugated Estrogens—Eye disorder—Temozolomide—malignant glioma	0.00138	0.00591	CcSEcCtD
Conjugated Estrogens—SLCO2B1—central nervous system—malignant glioma	0.00138	0.00704	CbGeAlD
Conjugated Estrogens—Cardiac disorder—Temozolomide—malignant glioma	0.00137	0.00586	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Carmustine—malignant glioma	0.00137	0.00584	CcSEcCtD
Conjugated Estrogens—Alopecia—Carmustine—malignant glioma	0.00135	0.00578	CcSEcCtD
Conjugated Estrogens—SLCO2B1—cerebellum—malignant glioma	0.00135	0.00688	CbGeAlD
Conjugated Estrogens—Angiopathy—Temozolomide—malignant glioma	0.00134	0.00573	CcSEcCtD
Conjugated Estrogens—Mental disorder—Carmustine—malignant glioma	0.00134	0.00573	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Temozolomide—malignant glioma	0.00134	0.00571	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Temozolomide—malignant glioma	0.00133	0.00569	CcSEcCtD
Conjugated Estrogens—Erythema—Carmustine—malignant glioma	0.00133	0.00569	CcSEcCtD
Conjugated Estrogens—Malnutrition—Carmustine—malignant glioma	0.00133	0.00569	CcSEcCtD
Conjugated Estrogens—Alopecia—Temozolomide—malignant glioma	0.00131	0.00558	CcSEcCtD
Conjugated Estrogens—Mental disorder—Temozolomide—malignant glioma	0.0013	0.00554	CcSEcCtD
Conjugated Estrogens—Back pain—Carmustine—malignant glioma	0.00129	0.00551	CcSEcCtD
Conjugated Estrogens—Erythema—Temozolomide—malignant glioma	0.00129	0.0055	CcSEcCtD
Conjugated Estrogens—Malnutrition—Temozolomide—malignant glioma	0.00129	0.0055	CcSEcCtD
Conjugated Estrogens—SLCO1A2—central nervous system—malignant glioma	0.00127	0.00648	CbGeAlD
Conjugated Estrogens—Dysgeusia—Temozolomide—malignant glioma	0.00126	0.00539	CcSEcCtD
Conjugated Estrogens—Vision blurred—Carmustine—malignant glioma	0.00126	0.00536	CcSEcCtD
Conjugated Estrogens—ESR2—brain—malignant glioma	0.00125	0.00637	CbGeAlD
Conjugated Estrogens—Back pain—Temozolomide—malignant glioma	0.00125	0.00532	CcSEcCtD
Conjugated Estrogens—SLCO1A2—cerebellum—malignant glioma	0.00124	0.00633	CbGeAlD
Conjugated Estrogens—ABCC4—central nervous system—malignant glioma	0.00122	0.00624	CbGeAlD
Conjugated Estrogens—SLC22A8—central nervous system—malignant glioma	0.00121	0.00619	CbGeAlD
Conjugated Estrogens—Vision blurred—Temozolomide—malignant glioma	0.00121	0.00518	CcSEcCtD
Conjugated Estrogens—ABCG2—medulla oblongata—malignant glioma	0.00119	0.00609	CbGeAlD
Conjugated Estrogens—COMT—brain—malignant glioma	0.00119	0.00607	CbGeAlD
Conjugated Estrogens—ABCC3—brain—malignant glioma	0.00118	0.006	CbGeAlD
Conjugated Estrogens—Angioedema—Temozolomide—malignant glioma	0.00118	0.00503	CcSEcCtD
Conjugated Estrogens—Vertigo—Temozolomide—malignant glioma	0.00116	0.00494	CcSEcCtD
Conjugated Estrogens—Convulsion—Carmustine—malignant glioma	0.00115	0.00493	CcSEcCtD
Conjugated Estrogens—Palpitations—Temozolomide—malignant glioma	0.00114	0.00486	CcSEcCtD
Conjugated Estrogens—Myalgia—Carmustine—malignant glioma	0.00113	0.00485	CcSEcCtD
Conjugated Estrogens—Chest pain—Carmustine—malignant glioma	0.00113	0.00485	CcSEcCtD
Conjugated Estrogens—Anxiety—Carmustine—malignant glioma	0.00113	0.00483	CcSEcCtD
Conjugated Estrogens—Cough—Temozolomide—malignant glioma	0.00112	0.0048	CcSEcCtD
Conjugated Estrogens—Ethinyl Estradiol—CYP2B6—malignant glioma	0.00112	0.534	CrCbGaD
Conjugated Estrogens—Convulsion—Temozolomide—malignant glioma	0.00112	0.00477	CcSEcCtD
Conjugated Estrogens—SLCO2B1—brain—malignant glioma	0.0011	0.00559	CbGeAlD
Conjugated Estrogens—Arthralgia—Temozolomide—malignant glioma	0.0011	0.00468	CcSEcCtD
Conjugated Estrogens—Myalgia—Temozolomide—malignant glioma	0.0011	0.00468	CcSEcCtD
Conjugated Estrogens—Anxiety—Temozolomide—malignant glioma	0.00109	0.00467	CcSEcCtD
Conjugated Estrogens—ABCG2—midbrain—malignant glioma	0.00109	0.00556	CbGeAlD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00109	0.00465	CcSEcCtD
Conjugated Estrogens—Oedema—Carmustine—malignant glioma	0.00109	0.00465	CcSEcCtD
Conjugated Estrogens—Infection—Carmustine—malignant glioma	0.00108	0.00462	CcSEcCtD
Conjugated Estrogens—ESR1—central nervous system—malignant glioma	0.00108	0.0055	CbGeAlD
Conjugated Estrogens—ABCG2—spinal cord—malignant glioma	0.00106	0.00543	CbGeAlD
Conjugated Estrogens—Tachycardia—Carmustine—malignant glioma	0.00106	0.00453	CcSEcCtD
Conjugated Estrogens—ESR1—cerebellum—malignant glioma	0.00105	0.00537	CbGeAlD
Conjugated Estrogens—Oedema—Temozolomide—malignant glioma	0.00105	0.00449	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Temozolomide—malignant glioma	0.00105	0.00449	CcSEcCtD
Conjugated Estrogens—Infection—Temozolomide—malignant glioma	0.00104	0.00446	CcSEcCtD
Conjugated Estrogens—Anorexia—Carmustine—malignant glioma	0.00104	0.00443	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Temozolomide—malignant glioma	0.00103	0.0044	CcSEcCtD
Conjugated Estrogens—Skin disorder—Temozolomide—malignant glioma	0.00102	0.00436	CcSEcCtD
Conjugated Estrogens—ABCC1—cerebellum—malignant glioma	0.00102	0.0052	CbGeAlD
Conjugated Estrogens—Hypotension—Carmustine—malignant glioma	0.00102	0.00434	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Temozolomide—malignant glioma	0.00102	0.00434	CcSEcCtD
Conjugated Estrogens—SLCO1A2—brain—malignant glioma	0.00101	0.00514	CbGeAlD
Conjugated Estrogens—Anorexia—Temozolomide—malignant glioma	0.001	0.00428	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000991	0.00423	CcSEcCtD
Conjugated Estrogens—Insomnia—Carmustine—malignant glioma	0.000984	0.0042	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Carmustine—malignant glioma	0.000976	0.00417	CcSEcCtD
Conjugated Estrogens—Estrone—CYP2B6—malignant glioma	0.000976	0.465	CrCbGaD
Conjugated Estrogens—ABCC4—brain—malignant glioma	0.000971	0.00495	CbGeAlD
Conjugated Estrogens—Dyspnoea—Carmustine—malignant glioma	0.00097	0.00414	CcSEcCtD
Conjugated Estrogens—Somnolence—Carmustine—malignant glioma	0.000967	0.00413	CcSEcCtD
Conjugated Estrogens—SLC22A8—brain—malignant glioma	0.000964	0.00491	CbGeAlD
Conjugated Estrogens—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000957	0.00409	CcSEcCtD
Conjugated Estrogens—Insomnia—Temozolomide—malignant glioma	0.00095	0.00406	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Carmustine—malignant glioma	0.000945	0.00404	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Temozolomide—malignant glioma	0.000944	0.00403	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Carmustine—malignant glioma	0.000939	0.00401	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Temozolomide—malignant glioma	0.000937	0.004	CcSEcCtD
Conjugated Estrogens—Somnolence—Temozolomide—malignant glioma	0.000934	0.00399	CcSEcCtD
Conjugated Estrogens—Pain—Carmustine—malignant glioma	0.00093	0.00397	CcSEcCtD
Conjugated Estrogens—Constipation—Carmustine—malignant glioma	0.00093	0.00397	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Temozolomide—malignant glioma	0.000925	0.00395	CcSEcCtD
Conjugated Estrogens—ABCB1—embryo—malignant glioma	0.000921	0.0047	CbGeAlD
Conjugated Estrogens—Decreased appetite—Temozolomide—malignant glioma	0.000914	0.0039	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000907	0.00388	CcSEcCtD
Conjugated Estrogens—Fatigue—Temozolomide—malignant glioma	0.000906	0.00387	CcSEcCtD
Conjugated Estrogens—Pain—Temozolomide—malignant glioma	0.000899	0.00384	CcSEcCtD
Conjugated Estrogens—Constipation—Temozolomide—malignant glioma	0.000899	0.00384	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Carmustine—malignant glioma	0.000889	0.0038	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Carmustine—malignant glioma	0.00086	0.00367	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Carmustine—malignant glioma	0.00086	0.00367	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Temozolomide—malignant glioma	0.000859	0.00367	CcSEcCtD
Conjugated Estrogens—ESR1—brain—malignant glioma	0.000856	0.00436	CbGeAlD
Conjugated Estrogens—ABCG2—cerebellum—malignant glioma	0.000844	0.0043	CbGeAlD
Conjugated Estrogens—Urticaria—Temozolomide—malignant glioma	0.000835	0.00357	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Temozolomide—malignant glioma	0.000831	0.00355	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Temozolomide—malignant glioma	0.000831	0.00355	CcSEcCtD
Conjugated Estrogens—ABCC1—brain—malignant glioma	0.000828	0.00422	CbGeAlD
Conjugated Estrogens—ABCB1—retina—malignant glioma	0.000815	0.00415	CbGeAlD
Conjugated Estrogens—Hypersensitivity—Carmustine—malignant glioma	0.000801	0.00342	CcSEcCtD
Conjugated Estrogens—Asthenia—Carmustine—malignant glioma	0.00078	0.00333	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Temozolomide—malignant glioma	0.000774	0.00331	CcSEcCtD
Conjugated Estrogens—Asthenia—Temozolomide—malignant glioma	0.000754	0.00322	CcSEcCtD
Conjugated Estrogens—ABCB1—telencephalon—malignant glioma	0.000749	0.00382	CbGeAlD
Conjugated Estrogens—Diarrhoea—Carmustine—malignant glioma	0.000744	0.00318	CcSEcCtD
Conjugated Estrogens—Pruritus—Temozolomide—malignant glioma	0.000744	0.00318	CcSEcCtD
Conjugated Estrogens—Dizziness—Carmustine—malignant glioma	0.000719	0.00307	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Temozolomide—malignant glioma	0.000719	0.00307	CcSEcCtD
Conjugated Estrogens—Dizziness—Temozolomide—malignant glioma	0.000695	0.00297	CcSEcCtD
Conjugated Estrogens—Vomiting—Carmustine—malignant glioma	0.000691	0.00295	CcSEcCtD
Conjugated Estrogens—ABCG2—brain—malignant glioma	0.000686	0.0035	CbGeAlD
Conjugated Estrogens—Rash—Carmustine—malignant glioma	0.000686	0.00293	CcSEcCtD
Conjugated Estrogens—Dermatitis—Carmustine—malignant glioma	0.000685	0.00293	CcSEcCtD
Conjugated Estrogens—Headache—Carmustine—malignant glioma	0.000681	0.00291	CcSEcCtD
Conjugated Estrogens—Vomiting—Temozolomide—malignant glioma	0.000668	0.00285	CcSEcCtD
Conjugated Estrogens—Rash—Temozolomide—malignant glioma	0.000663	0.00283	CcSEcCtD
Conjugated Estrogens—Dermatitis—Temozolomide—malignant glioma	0.000662	0.00283	CcSEcCtD
Conjugated Estrogens—Headache—Temozolomide—malignant glioma	0.000658	0.00281	CcSEcCtD
Conjugated Estrogens—Nausea—Carmustine—malignant glioma	0.000646	0.00276	CcSEcCtD
Conjugated Estrogens—Nausea—Temozolomide—malignant glioma	0.000624	0.00267	CcSEcCtD
Conjugated Estrogens—CYP3A4—central nervous system—malignant glioma	0.000602	0.00307	CbGeAlD
Conjugated Estrogens—ABCB1—medulla oblongata—malignant glioma	0.000589	0.003	CbGeAlD
Conjugated Estrogens—ABCB1—midbrain—malignant glioma	0.000538	0.00274	CbGeAlD
Conjugated Estrogens—ABCB1—spinal cord—malignant glioma	0.000525	0.00268	CbGeAlD
Conjugated Estrogens—ABCB1—central nervous system—malignant glioma	0.000426	0.00217	CbGeAlD
Conjugated Estrogens—ABCB1—cerebellum—malignant glioma	0.000416	0.00212	CbGeAlD
Conjugated Estrogens—ABCB1—brain—malignant glioma	0.000338	0.00172	CbGeAlD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.69e-05	0.000122	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GSTP1—malignant glioma	3.66e-05	0.000121	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCR3—malignant glioma	3.65e-05	0.000121	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—COX8A—malignant glioma	3.65e-05	0.000121	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2B6—malignant glioma	3.59e-05	0.000119	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CAT—malignant glioma	3.57e-05	0.000118	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—YWHAE—malignant glioma	3.55e-05	0.000118	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NTRK2—malignant glioma	3.55e-05	0.000118	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TERT—malignant glioma	3.54e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HLA-A—malignant glioma	3.54e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FLT1—malignant glioma	3.54e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CG—malignant glioma	3.54e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.53e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—DUSP6—malignant glioma	3.52e-05	0.000117	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.52e-05	0.000116	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CAV1—malignant glioma	3.5e-05	0.000116	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GSTP1—malignant glioma	3.48e-05	0.000115	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JAG1—malignant glioma	3.48e-05	0.000115	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH3—malignant glioma	3.46e-05	0.000115	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PDGFB—malignant glioma	3.46e-05	0.000114	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—PIK3CA—malignant glioma	3.46e-05	0.000114	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.44e-05	0.000114	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FGFR1—malignant glioma	3.44e-05	0.000114	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PPARG—malignant glioma	3.41e-05	0.000113	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FBXW7—malignant glioma	3.41e-05	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HIF1A—malignant glioma	3.39e-05	0.000112	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CAT—malignant glioma	3.39e-05	0.000112	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NCOR1—malignant glioma	3.37e-05	0.000111	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.35e-05	0.000111	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—malignant glioma	3.34e-05	0.000111	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BDKRB2—malignant glioma	3.34e-05	0.000111	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CB—malignant glioma	3.32e-05	0.00011	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—malignant glioma	3.3e-05	0.000109	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTGS2—malignant glioma	3.29e-05	0.000109	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—IDH1—malignant glioma	3.28e-05	0.000109	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.28e-05	0.000108	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CAV1—malignant glioma	3.28e-05	0.000108	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.25e-05	0.000108	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTP1—malignant glioma	3.22e-05	0.000107	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NCOR1—malignant glioma	3.2e-05	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CG—malignant glioma	3.19e-05	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SPHK1—malignant glioma	3.17e-05	0.000105	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—malignant glioma	3.16e-05	0.000104	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CAT—malignant glioma	3.14e-05	0.000104	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2C18—malignant glioma	3.11e-05	0.000103	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CD—malignant glioma	3.11e-05	0.000103	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH2—malignant glioma	3.11e-05	0.000103	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ASMT—malignant glioma	3.1e-05	0.000103	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—BAD—malignant glioma	3.08e-05	0.000102	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PPARG—malignant glioma	3.08e-05	0.000102	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOTCH1—malignant glioma	3.05e-05	0.000101	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CAV1—malignant glioma	3.05e-05	0.000101	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—IDH2—malignant glioma	3.05e-05	0.000101	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KNG1—malignant glioma	3.04e-05	0.000101	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CD80—malignant glioma	2.99e-05	9.9e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.99e-05	9.89e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—APC—malignant glioma	2.99e-05	9.88e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NCOR1—malignant glioma	2.96e-05	9.81e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NOTCH1—malignant glioma	2.96e-05	9.78e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGF—malignant glioma	2.95e-05	9.77e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTPN11—malignant glioma	2.93e-05	9.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BCAN—malignant glioma	2.92e-05	9.65e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.91e-05	9.64e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NTRK1—malignant glioma	2.9e-05	9.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.89e-05	9.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.87e-05	9.5e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTEN—malignant glioma	2.87e-05	9.48e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2B6—malignant glioma	2.86e-05	9.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—AKT1—malignant glioma	2.82e-05	9.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—BRAF—malignant glioma	2.81e-05	9.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CD—malignant glioma	2.81e-05	9.28e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—PPARG—malignant glioma	2.79e-05	9.23e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CG—malignant glioma	2.78e-05	9.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CAV1—malignant glioma	2.74e-05	9.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT2—malignant glioma	2.73e-05	9.04e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CB—malignant glioma	2.71e-05	8.97e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP3—malignant glioma	2.69e-05	8.91e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—malignant glioma	2.69e-05	8.89e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PPARG—malignant glioma	2.68e-05	8.87e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN2B—malignant glioma	2.67e-05	8.83e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PIK3CA—malignant glioma	2.64e-05	8.73e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CD—malignant glioma	2.62e-05	8.69e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.62e-05	8.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—IDH1—malignant glioma	2.62e-05	8.67e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CAV1—malignant glioma	2.61e-05	8.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTK2—malignant glioma	2.59e-05	8.58e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HES1—malignant glioma	2.55e-05	8.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SPHK1—malignant glioma	2.53e-05	8.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NCOR1—malignant glioma	2.53e-05	8.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTT1—malignant glioma	2.51e-05	8.32e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FGF2—malignant glioma	2.51e-05	8.32e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CG—malignant glioma	2.5e-05	8.27e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.49e-05	8.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.48e-05	8.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CB—malignant glioma	2.45e-05	8.09e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CD—malignant glioma	2.44e-05	8.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.44e-05	8.08e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PDGFRA—malignant glioma	2.42e-05	8.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—malignant glioma	2.42e-05	8.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CAV1—malignant glioma	2.42e-05	7.99e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PPARG—malignant glioma	2.41e-05	7.99e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CG—malignant glioma	2.38e-05	7.86e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS1—malignant glioma	2.36e-05	7.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SPP1—malignant glioma	2.35e-05	7.79e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MDM2—malignant glioma	2.35e-05	7.78e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—IDH2—malignant glioma	2.35e-05	7.78e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—RAF1—malignant glioma	2.34e-05	7.75e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTEN—malignant glioma	2.34e-05	7.75e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.34e-05	7.75e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—malignant glioma	2.32e-05	7.67e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PPARG—malignant glioma	2.29e-05	7.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CB—malignant glioma	2.29e-05	7.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—malignant glioma	2.27e-05	7.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—malignant glioma	2.23e-05	7.38e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.21e-05	7.31e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CG—malignant glioma	2.2e-05	7.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CD—malignant glioma	2.2e-05	7.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—BCHE—malignant glioma	2.19e-05	7.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—malignant glioma	2.19e-05	7.24e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PDGFB—malignant glioma	2.18e-05	7.21e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGFR1—malignant glioma	2.17e-05	7.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC5A5—malignant glioma	2.16e-05	7.16e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—malignant glioma	2.15e-05	7.13e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—malignant glioma	2.13e-05	7.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.13e-05	7.06e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—malignant glioma	2.13e-05	7.05e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PPARG—malignant glioma	2.12e-05	7.03e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—malignant glioma	2.11e-05	6.99e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—malignant glioma	2.11e-05	6.98e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—malignant glioma	2.09e-05	6.91e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CAV1—malignant glioma	2.06e-05	6.83e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.06e-05	6.81e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—malignant glioma	2.04e-05	6.75e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—malignant glioma	2.02e-05	6.69e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—IDH1—malignant glioma	2.02e-05	6.69e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—malignant glioma	2.01e-05	6.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.99e-05	6.6e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—malignant glioma	1.98e-05	6.54e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—F2—malignant glioma	1.96e-05	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FN1—malignant glioma	1.96e-05	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SPHK1—malignant glioma	1.96e-05	6.47e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BAD—malignant glioma	1.94e-05	6.42e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—malignant glioma	1.93e-05	6.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH1—malignant glioma	1.92e-05	6.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—malignant glioma	1.92e-05	6.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.92e-05	6.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—malignant glioma	1.9e-05	6.28e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CD80—malignant glioma	1.88e-05	6.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS1—malignant glioma	1.88e-05	6.23e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—malignant glioma	1.88e-05	6.22e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—malignant glioma	1.88e-05	6.22e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.87e-05	6.2e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGF—malignant glioma	1.86e-05	6.15e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTPN11—malignant glioma	1.85e-05	6.11e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—malignant glioma	1.84e-05	6.09e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—malignant glioma	1.82e-05	6.03e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—malignant glioma	1.8e-05	5.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—malignant glioma	1.77e-05	5.85e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—malignant glioma	1.77e-05	5.85e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BCHE—malignant glioma	1.75e-05	5.79e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—malignant glioma	1.74e-05	5.77e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.73e-05	5.72e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT2—malignant glioma	1.72e-05	5.69e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAT—malignant glioma	1.7e-05	5.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—malignant glioma	1.69e-05	5.58e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—malignant glioma	1.67e-05	5.53e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—malignant glioma	1.66e-05	5.48e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—malignant glioma	1.65e-05	5.47e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—malignant glioma	1.65e-05	5.47e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—malignant glioma	1.65e-05	5.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—malignant glioma	1.64e-05	5.44e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.63e-05	5.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.62e-05	5.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—malignant glioma	1.61e-05	5.32e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NCOR1—malignant glioma	1.6e-05	5.3e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—malignant glioma	1.59e-05	5.26e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGF2—malignant glioma	1.58e-05	5.24e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—malignant glioma	1.57e-05	5.21e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—malignant glioma	1.55e-05	5.13e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—malignant glioma	1.52e-05	5.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—malignant glioma	1.49e-05	4.93e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—malignant glioma	1.48e-05	4.9e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RAF1—malignant glioma	1.48e-05	4.88e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—malignant glioma	1.46e-05	4.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—malignant glioma	1.46e-05	4.82e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS1—malignant glioma	1.45e-05	4.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—malignant glioma	1.44e-05	4.77e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.41e-05	4.67e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—malignant glioma	1.39e-05	4.62e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—malignant glioma	1.39e-05	4.61e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—malignant glioma	1.38e-05	4.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAT—malignant glioma	1.35e-05	4.48e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BCHE—malignant glioma	1.35e-05	4.47e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—malignant glioma	1.35e-05	4.47e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.33e-05	4.41e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—malignant glioma	1.32e-05	4.38e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—malignant glioma	1.32e-05	4.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAV1—malignant glioma	1.31e-05	4.32e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—malignant glioma	1.3e-05	4.3e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOR1—malignant glioma	1.28e-05	4.23e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—malignant glioma	1.25e-05	4.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—malignant glioma	1.24e-05	4.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—malignant glioma	1.22e-05	4.03e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—malignant glioma	1.19e-05	3.94e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—malignant glioma	1.17e-05	3.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPARG—malignant glioma	1.15e-05	3.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—malignant glioma	1.14e-05	3.77e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—malignant glioma	1.12e-05	3.72e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—malignant glioma	1.11e-05	3.68e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.11e-05	3.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—malignant glioma	1.1e-05	3.65e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—malignant glioma	1.07e-05	3.55e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—malignant glioma	1.06e-05	3.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—malignant glioma	1.05e-05	3.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAT—malignant glioma	1.05e-05	3.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAV1—malignant glioma	1.04e-05	3.45e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—malignant glioma	1.03e-05	3.42e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—malignant glioma	1.03e-05	3.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—malignant glioma	1.01e-05	3.35e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.96e-06	3.3e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOR1—malignant glioma	9.87e-06	3.27e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—malignant glioma	9.56e-06	3.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—malignant glioma	9.54e-06	3.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—malignant glioma	9.5e-06	3.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPARG—malignant glioma	9.16e-06	3.03e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—malignant glioma	9.11e-06	3.02e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—malignant glioma	9.07e-06	3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—malignant glioma	9.03e-06	2.99e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—malignant glioma	8.78e-06	2.91e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—malignant glioma	8.49e-06	2.81e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—malignant glioma	8.4e-06	2.78e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—malignant glioma	8.35e-06	2.76e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAV1—malignant glioma	8.05e-06	2.66e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—malignant glioma	7.88e-06	2.61e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.33e-06	2.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—malignant glioma	7.28e-06	2.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—malignant glioma	7.21e-06	2.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—malignant glioma	7.17e-06	2.37e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPARG—malignant glioma	7.07e-06	2.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.44e-06	2.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—malignant glioma	6.29e-06	2.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.62e-06	1.86e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—malignant glioma	5.56e-06	1.84e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—malignant glioma	5.56e-06	1.84e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—malignant glioma	4.85e-06	1.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—malignant glioma	4.54e-06	1.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.44e-06	1.47e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—malignant glioma	3.62e-06	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.42e-06	1.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—malignant glioma	2.8e-06	9.25e-06	CbGpPWpGaD
